Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginia Borges

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responsesDavid Avigan, Baldev Vasir, Jianlin Gong, et al.
Journal of the National Cancer Institute|June 19, 2015
Important Role of Menarche in Development of Estrogen Receptor-Negative Breast Cancer in African American WomenChristine B Ambrosone, Gary Zirpoli, Chi-Chen Hong, et al.
Journal of the National Cancer Institute|September 17, 2014
Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER ConsortiumJulie R Palmer, Emma Viscidi, Melissa A Troester, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2008
Urinary metalloproteinases: noninvasive biomarkers for breast cancer risk assessmentSusan E Pories, David Zurakowski, Roopali Roy, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2023
Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progressionJun Nishida, Simona Cristea, Sudheshna Bodapati, et al.
Practical Radiation Oncology|June 28, 2016
Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastasesHania A Al-Hallaq, Steven Chmura, Joseph K Salama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2025
Association of tumor-infiltrating lymphocyte subtypes with clinical characteristics and prognosis in young women with hormone receptor-positive breast cancerMegan E Tesch, Yue Zheng, Yaileen D Guzman-Arocho, et al.
JAMA Oncology|April 22, 2021
Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases: Findings From the NRG-BR001 Phase 1 TrialSteve Chmura, Kathryn A Winter, Clifford Robinson, et al.
Plos One|March 13, 2020
Correction: Evaluation of significant genome-wide association studies risk-SNPs in young breast cancer patientsMichelle Rath, Qiyuan Li, Huili Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2025
Phase 2 trial of imprime and pembrolizumab immunotherapy in metastatic triple negative breast cancer patients who have progressed beyond first line chemotherapyAlison T Stopeck, Maysa Abu-Khalaf, Virginia Borges, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responsesDavid Avigan, Baldev Vasir, Jianlin Gong, et al.
Journal of the National Cancer Institute|June 19, 2015
Important Role of Menarche in Development of Estrogen Receptor-Negative Breast Cancer in African American WomenChristine B Ambrosone, Gary Zirpoli, Chi-Chen Hong, et al.
Journal of the National Cancer Institute|September 17, 2014
Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER ConsortiumJulie R Palmer, Emma Viscidi, Melissa A Troester, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2008
Urinary metalloproteinases: noninvasive biomarkers for breast cancer risk assessmentSusan E Pories, David Zurakowski, Roopali Roy, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2023
Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progressionJun Nishida, Simona Cristea, Sudheshna Bodapati, et al.
Practical Radiation Oncology|June 28, 2016
Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastasesHania A Al-Hallaq, Steven Chmura, Joseph K Salama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2025
Association of tumor-infiltrating lymphocyte subtypes with clinical characteristics and prognosis in young women with hormone receptor-positive breast cancerMegan E Tesch, Yue Zheng, Yaileen D Guzman-Arocho, et al.
JAMA Oncology|April 22, 2021
Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases: Findings From the NRG-BR001 Phase 1 TrialSteve Chmura, Kathryn A Winter, Clifford Robinson, et al.
Plos One|March 13, 2020
Correction: Evaluation of significant genome-wide association studies risk-SNPs in young breast cancer patientsMichelle Rath, Qiyuan Li, Huili Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2025
Phase 2 trial of imprime and pembrolizumab immunotherapy in metastatic triple negative breast cancer patients who have progressed beyond first line chemotherapyAlison T Stopeck, Maysa Abu-Khalaf, Virginia Borges, et al.
Pageof 4